Candid Therapeutics Enters into Agreement with WuXi Biologics on Trispecific T-cell Engager
Candid Therapeutics, Inc. ("Candid"), a clinical-stage biotechnology company focused on becoming the leader in advancing ...
Grupo Aeroportuario del Pacifico Reports in December 2024 a Passenger Traffic Increase of 2.9% Compared to 2023
GUADALAJARA, Mexico, Jan. 06, 2025 (GLOBE NEWSWIRE) -- , (NYSE: PAC; BMV: GAP) (“the Company” or “GAP”) announces preliminary terminal passenger traffic figures for December 2024, compared with ...